The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
Publication date
2022-10
Authors
Filippi, Luca
Braat, A. J.A.T.
Schillaci, Orazio
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Antigens, Surface, Carcinoma, Hepatocellular/diagnostic imaging, Glutamate Carboxypeptidase II, Humans, Liver Neoplasms/diagnostic imaging, Male, Precision Medicine, Prostate-Specific Antigen, Prostate/pathology, Prostatic Neoplasms/diagnostic imaging, Taverne, Radiology Nuclear Medicine and imaging, Comment, Letter
Citation
Filippi, L, Braat, A J & Schillaci, O 2022, 'The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming : are we ready for it?', European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 12, pp. 3977-3978. https://doi.org/10.1007/s00259-022-05928-0